1. Home
  2. Government
  3. Policy Library
  4. Industry, Innovation & IP
  5. Biomedicine & Medical Devices

Several Measures to Promote High-Quality Development of Innovative Drugs

China's healthcare security authority has announced a series of measures to encourage novel drug development, including the creation of a commercial insurance catalog for innovative medicines that patients could be reimbursed for.

Issuing Authority: National Health Commission of the People’s Republic of China

Issued on: June 30, 2025

Effective Date: From date of issuance

Applicable Area: Nation-wide

Type: National Policy

 

1200-Full Text.png

Chinese

 

1200-explainer.png

Frequently Asked Questions

Do I need a physical marriage certificate when applying for a residence permit for private affairs?

Residence permit

Do I need to declare my ADHD medication to customs during an airside transit at Shanghai Pudong Airport?

Customs

Is Wusongkou International Cruise Terminal an eligible port under the 240-hr visa-free transit policy?

Visa-free transit

To reach International Services Shanghai, email us at